by Eric Christianson | Apr 19, 2026 | Respiratory Medication and Disease State Clinical Pearls
Beta-blockers have long been approached with caution in patients with asthma due to their potential to provoke bronchospasm and blunt the effects of rescue inhalers. This risk is largely driven by receptor selectivity. In this article, we will break down the best and...
by Eric Christianson | Apr 15, 2026 | Hematology and Immunology Medication and Disease State Clinical Pearls
Epoetin alfa (Epogen/Procrit) is a medication pharmacists commonly encounter in long-term care, dialysis, and oncology settings. While its role in stimulating red blood cell production seems straightforward, there are several key clinical pearls that are essential to...
by Eric Christianson | Apr 1, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
SSRIs are the drug of choice for many conditions. That is true of both obsessive-compulsive disorder and depression (excellent board exam nugget to remember). As you are reviewing a patient’s medication list or potentially helping with that patient’s...
by Eric Christianson | Mar 29, 2026 | Neurology, Pain, and Musculoskeletal Case Studies
A recent case prompted me to create a blog post about tapering seizure medications. Tapering and discontinuing anti-seizure medications is a delicate process that requires close clinical monitoring and a strategic approach to achieve long-term seizure control for...
by Eric Christianson | Mar 25, 2026 | Cardiovascular Case Studies
If you’ve come to this page, you likely know the basics of anticoagulation but are looking to expand that knowledge for better clinical practice. Xarelto and Eliquis are both direct oral anticoagulants (DOACs) that directly bind clotting factor Xa to reduce fibrin...
